Advances in medicine causes new, groundbreaking drug by Quantum Genomics (QNNTF) to help with the chronic hypertension

Quantum Genomics are the creators of Firibastat, a first in class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to  interfere with the renin-angiotensin system. For details visit:

Go Back